Search - tctmd.com

Displaying 1 - 20 of 65

Sort: Relevancy | Date

News Conference News TVT 2023

‘Excellent’ Outcomes With Mitral ViV Procedures, Even in Lower-Risk Patients

Michael O'Riordan

June 09, 2023

Presentation TVT 2023

LATE BREAKING INNOVATION: Transcatheter Edge-to-Edge Repair for Tricuspid Regurgitation: Comparing the TRILUMINATE™ Pivotal and bRIGHT Clinical Trials

Presenter: Paul Sorajja

June 09, 2023

Presentation TVT 2023

Update From the Clinical Trials and Where I Would and Wouldn’t Use It

Presenter: Basel Ramlawi

June 08, 2023

Presentation TVT 2023

Update From the Clinical Trials and Where I Would and Wouldn’t Use It

Presenter: Azeem Latib

June 08, 2023

Presentation TVT 2023

Etiologies of Exclusion Rates for Transcatheter Mitral and Tricuspid Valve Structural Heart Clinical Trials at a High volume Quaternary Care Hospital

Presenter: Lu Chen

June 08, 2023

News Features TVT 2022

Minorities, Poorer Patients Missing Out on Structural Heart Care

Michael O'Riordan

June 15, 2022

News Conference News TVT 2022

Less Paravalvular Leak With Newer Acurate neo2 TAVI: Registry

Michael O'Riordan

June 13, 2022

Presentation TVT 2022

TVARC Safety and Efficacy Endpoint Recommended for Clinical Trials

Presenter: Mahesh V. Madhavan

June 10, 2022

Presentation TVT 2022

Quality-of-life Assessments and Cost-effectiveness Analyses in TTVI Trials

Presenter: Geraldine Ong, Gilbert H. L. Tang, Yan Topilsky

June 10, 2022

News Conference News TVT 2022

No Stroke Reduction With Embolic Protection in TAVI, Two Studies Suggest

Michael O'Riordan

June 09, 2022

Presentation TVT 2022

Characteristics of Clinical Trial Sites for Novel Transcatheter Mitral and Tricuspid Valvular Therapies – Inequities in Access to Clinical Trials

Presenter: Ashwin Nathan

June 08, 2022

Presentation TVT 2022

First Report of Outcomes of TEER in Patients With Endocardial Leads: Insights From TRILUMINATE and bRIGHT Clinical Trials

Presenter: Georg Nickenig

June 08, 2022

Presentation TVT 2022

Heterotopic Tricuspid Valve Replacement: Considerations for Future Clinical Trials

Presenter: Ori Ben-Yehuda

June 08, 2022

Presentation TVT 2022

From National Registries to Pragmatic Clinical Trials, From Patient-Reported Outcomes to Shared Decision-making: Not One Size Fits All!

Presenter: Sreekanth Vemulapalli

June 08, 2022

Presentation TVT 2022

Transcatheter versus surgical aortic valve replacement for severe aortic stenosis: a meta-analysis of randomized clinical trials

Presenter: Yousif Ahmad

June 08, 2022

News Conference News TVT 2021

New-Generation Watchman FLX Maintains Good Results Through 2 Years

Todd Neale

July 28, 2021

News Conference News TVT 2021

Optimizing Medical Therapy Before Clip Repair for MR? ‘This Is Hard’

Todd Neale

July 27, 2021

Presentation TVT 2021

Percutaneous Left Atrial Appendage Closure Versus Oral Anticoagulation for Non-Valvular Atrial Fibrillation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Presenter: Yousif Ahmad

July 22, 2021

Presentation TVT 2021

Implications of COVID-19 Related Reductions of HF Hospitalizations on Clinical Trials of HF Devices

Presenter: JoAnn Lindenfeld

July 22, 2021

Presentation TVT 2021

How Changes in GDMT for HF Are Impacting Clinical Trials of HF Devices

Presenter: Susan M. Joseph

July 22, 2021

Advertisement

‘Excellent’ Outcomes With Mitral ViV Procedures, Even in Lower-Risk Patients

LATE BREAKING INNOVATION: Transcatheter Edge-to-Edge Repair for Tricuspid Regurgitation: Comparing the TRILUMINATE™ Pivotal and bRIGHT Clinical Trials

Update From the Clinical Trials and Where I Would and Wouldn’t Use It

Update From the Clinical Trials and Where I Would and Wouldn’t Use It

Etiologies of Exclusion Rates for Transcatheter Mitral and Tricuspid Valve Structural Heart Clinical Trials at a High volume Quaternary Care Hospital

Minorities, Poorer Patients Missing Out on Structural Heart Care

Less Paravalvular Leak With Newer Acurate neo2 TAVI: Registry

TVARC Safety and Efficacy Endpoint Recommended for Clinical Trials

Quality-of-life Assessments and Cost-effectiveness Analyses in TTVI Trials

No Stroke Reduction With Embolic Protection in TAVI, Two Studies Suggest

Characteristics of Clinical Trial Sites for Novel Transcatheter Mitral and Tricuspid Valvular Therapies – Inequities in Access to Clinical Trials

First Report of Outcomes of TEER in Patients With Endocardial Leads: Insights From TRILUMINATE and bRIGHT Clinical Trials

Heterotopic Tricuspid Valve Replacement: Considerations for Future Clinical Trials

From National Registries to Pragmatic Clinical Trials, From Patient-Reported Outcomes to Shared Decision-making: Not One Size Fits All!

Transcatheter versus surgical aortic valve replacement for severe aortic stenosis: a meta-analysis of randomized clinical trials

New-Generation Watchman FLX Maintains Good Results Through 2 Years

Optimizing Medical Therapy Before Clip Repair for MR? ‘This Is Hard’

Percutaneous Left Atrial Appendage Closure Versus Oral Anticoagulation for Non-Valvular Atrial Fibrillation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Implications of COVID-19 Related Reductions of HF Hospitalizations on Clinical Trials of HF Devices

How Changes in GDMT for HF Are Impacting Clinical Trials of HF Devices

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content